POTOMAC FUND MANAGEMENT INC /ADV

Position in LLY — ELI LILLY & Co

CIK 826000 BETHESDA, MD

Position in LLY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$706,464

+$98,497 QoQ

Shares Held

589

-10.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.78%

of 13F equity value

Holder Rank

#3,443

of 4,605 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

POTOMAC FUND MANAGEMENT INC /ADV holds $5,661,580 across 4 Drug Manufacturers - General names. LLY ranks #4 (12.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	16,241	$2,051,887
2	AZN	Astrazeneca PLC	10,398	$1,971,668
3	JNJ	Johnson & Johnson	3,668	$931,561
4	LLY	ELI LILLY & Co This page	589	$706,464

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$706,464	589	-10.9%	Shares	Sole	2026-08-13
2026-03-31	$607,967	661	-0.5%	Shares	Sole	2026-05-14
2025-12-31	$713,587	664	+27.9%	Shares	Sole	2026-02-13
2025-09-30	$395,997	519	+39.5%	Shares	Sole	2025-11-12
2025-06-30	$289,985	372	+7.5%	Shares	Sole	2025-10-02
2025-03-31	$285,764	346	—	Shares	Sole	2025-10-02
No filing history on record for this holder in this stock.